• 대한수의학회지
• /
• 제35권4호
• /
• pp.769-776
• /
• 1995

This study was undertaken to develop the monoclonal antibody(MAb) for lymphocytes of Korean native cattle by the cell hybridization of myeloma P3/NS-1/ 1-Ag-4-1 and spleen cells from BALB/c mice hyperimmunized with nylon wool column eluted peripheral T lymphocytes of Korean native cattle. The isotype of MAb KCT-14 against T lymphocyte was mouse $IgG_1$. KCT-14 positivity of mononuclear cells(MNC) from peripheral blood lymphocytes, nylon wool nonadherent and adherent-lymphocytes was 41.7%, 58.4% and 22.6%, respectively. And that of mesenteric lymph node-, spleen and thymus-MNC was 43.3%, 40.2% and 33.6%, respectively. Immunoperoxidase staining of frozen tissue sections showed that the MAb positive cells were located in the medulla of the thymus and in the paracortical area and the mantle zone of the germinal center in the lymph nodes. These results indicated that KCT-14 was one of the MAb for investigate of T lymphocyte subpopulations in the Korean native cattle.

• 대한임상검사과학회지
• /
• 제38권1호
• /
• pp.9-15
• /
• 2006

Peripheral bood stem cell collection (PBSCC), including peripheral blood stem cell transplantation (PBSCT), has been utilized worldwide as a very beneficial treatment method instead of allogenic Bone Marrow Transplantation (BMT) because it has many advantages such as rapid bone marrow engraftment and hematopoietic recovery, easy and safe accessibility and lower risk of rejection compared with allogenic BMT. In order to identify most the observable parameter in PBSCC, we analyzed various hematological parameters before and after PBSCC, and evaluated the correlation between the time of bone marrow engraftment and the number of CD34+ cells. Thirteen patients, who underwent 54 PBSCCs from January, 2003 to August, 2004 at Chungnam National University Hospital due to various systemic neoplasms, were analyzed in aspects of various hematological parameters including CD34+ cells using by Flow Cytometry (FCM). PBSCC harvests are described below: Mononuclear cells (MNC) $2.3{\pm}1.4{\times}10^8/kg$ and CD34+ cells $0.63{\pm}0.35{\times}10^6/kg$ on average, respectively. There was a statistical significance in Hb and Hct before and after PBSCC, but not in WBC and platelet counts. The period to reach the hematological bone marrow engraftment was 13.4(10~21) days and 19.5(11~38) days according to the criteria of absolute neutrophile counts (ANC) ${\geq}500/uL$ and platelet counts ${\geq}50,000/{\mu}L$ in peripheral blood, respectively. There was a significant correlation between the numbers of CD34+ cell and ANC (p<0.05), and a borderline significance between MNC and ANC (p=0.051). We found that a group of patients, who were infused with CD34+ cells more than $3.5{\times}10^6/kg$, reached more rapidly the period of bone marrow engraftment in platelet counts (p=0.040). This present study suggested that Hb and Hct were the most useful parameters and should be closely monitored before and after PBSCC, that a PBSCT with the dosage of more than $3.5{\times}10^6/kg$ of CD34+ cells was needed to perform successful bone marrow engraftment, and additionally that platelet counts could be more useful in indicating bone marrow engraftment than ANC.

• Preventive Nutrition and Food Science
• /
• 제9권3호
• /
• pp.276-282
• /
• 2004

Marginal Zn deficiency is prevalent through the world and yet human zinc status has not been properly assessed due to the lack of a reliable diagnostic indicator. One potential possibility for zinc status assessment using Zn-binding protein, metallothionein (MT)-mRNA, has been proposed. The purpose of the present study was aimed to show whether measurement of mononuclear cell (MNC) MT mRNA, using a competitive-reverse transcriptase-polymerase chain reaction (competitive-RT-PCR) assay, could indicate zinc status in human subjects. In this study, MNC MT-mRNA expression was measured using a competitive-RT-PCR to compare before and after 14 days of zinc supplementation (50 mg Zn/das zinc gluconate). RT-PCR oligonucleotide primers which were designed to amplify both a 278 bp segment of the human MT-2A cDNA and a 198 bp mutant competitor cDNA template from MNCs, were prepared. MT-2A mRNA was normalized by reference to the housekeeping gene, $\beta$-actin, mRNA for which was also measured by competitive-RT-PCR. There was considerable inter-individual variation in MT-mRNA concentration and yet, the mean MT-2A mRNA level increased 4.7-fold after Zn supplementation, as compared to before Zn supplementation. This MT-2A mRNA level was shown as the same pattern and, even more sensitive assay, compared to the conventional plasma and red blood cells (RBCs) Zn assessment in which plasma and RBCs zinc levels increased 2.3- and 1.2-fold, respectively (p<0.05). We suggest that MT competitive-RT-PCR can be a useful assessment tool for evaluating human zinc status.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권15호
• /
• pp.6127-6130
• /
• 2014

Objective: Explore the feasibility of allo-hemopietic stem cell transplants in treating patients with B cell acute lymphocytic leukemia. Methods: Between september 2006 and February 2011, fifteen patients with B cell acute lymphocytic leukemia (ALL) were treated by allo-hemopietic stem cell transplants (HSCT). Stem cell sources were peripheral blood. Six patients were conditioned by busulfan (BU) and cyclophosphamide (CY) and nine patients were conditioned with TBI and cyclophosphamide (CY). Graft versus host disease (GVHD) prophylaxis regimen consisted of cyclosporine A (CSA), methotrex ate (MTX) and mycophenolatemofetil (MMF). Results: Patients received a median of $7.98{\times}10^8{\cdot}kg^{-1}$ ($5.36-12.30{\times}10^8{\cdot}kg^{-1}$) mononuclear cells (MNC). The median time of ANC> $0.5{\times}10^9/L$ was day 12 (10-15), and PLT> $20.0{\times}10^9/L$ was day 13 (11-16). Extensive acute GVHD occurred in 6 (40.0%) patients, and extensive chronic GVHD was recorded in 6 (40.0%) patients. Nine patients were alive after 2.5-65 months follow-up. Conclusion: Allogeneic stem cell transplant could be effective in treating patients with B cell acute lymphocytic leukemia.

• 대한수의학회지
• /
• 제32권2호
• /
• pp.175-179
• /
• 1992

돼지(n=22) 순환혈액내 단핵세포(PB-MNCs)중 T 및 B 림프구를 정량하고자 rosette 형성기법을 적용하였다. T 림프구는 여러 농도의 2-aminoethylisothiouronium bromide(Aet)나 dextran(Dex) 용액 또는 Aet와 Dex로 조합 처리된 면양(SRBC) 및 재래산양(GRBC)의 적혈구를 사용한 E-rosette 법으로, B 림프구는 erythrocyeantibody(EA) 및 erythrocyte-antibody-complement(EAC) rosette 법으로 각각 정량하였다. 한편 rosette 형성세포의 냉장정치시간에 따른 판독결과를 비교하여 적정판독시간대를 구명한 바 아래의 결과를 얻었다. 1. PB-MNCs와 SRBC/GRBC와의 자연 rosette형성을(RFR)은$ 32.9{\pm}7.9%/31.3{\pm}9.4%$인데 비하여 Aet 또는 Dex 처리군에서는 모두 증가되었고 특히 0.15M Aet$(40.2{\pm}4.6%/37.0{\pm}3.3%)$ 및 8% Dex$(71.5{\pm}4.5%/69.9{\pm}5.8%)$ 처리군에서 각각 높게 나타났다. 한편 0.1M Aet처리후 8% Dex 첨가군에서는 $67.8{\pm}7.4%$ 및 $69.8{\pm}8.5%$로 나타나 복잡한 Aet와 Dex를 복합처리하기 보다는 8% Dex 단독처리가 간편함을 알 수 있었다. 2. Rosette 형성세포의 냉장보관중 최적판독시간대는 10~20시간의 범위이었다. 3. EA 및 EAC의 RFR은 SRBC의 경우 $39.1{\pm}10.2%$, $27.6{\pm}7.0%$, GRBC의 경우 $32.6{\pm}6.1%$, $21.0{\pm}3.2%$로 나타났다. 이러한 결과는 돼지 PB-MNCs내의 T 및 B 림프구를 rosette 형성법으로 분리할 수 있으며 rosette assay에서 SRBC 뿐아니라 GRBC의 이용이 가능함을 제시한다.